| Factor Information | |
|---|---|
| Data ID | 1038 |
| Factor | procedural failurerate |
| Description | Compared with the non-CHD group, the CHD group had a significantly higher procedural failure rate (14% vs 7%, p = 0.01). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The objective was to compare DCCV procedural failure (failure to terminate the presenting arrhythmia) and arrhythmia recurrence (AR). |
| p Value | 0.01 |
| Conclusion | Compared with the non-CHD group, the CHD group had a significantly higher procedural failure rate (14% vs 7%, p = 0.01). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 497 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
| Reference | |
|---|---|
| PMID | 28262200 |
| Year | 2017 |
| Title | Outcomes of Direct Current Cardioversion in Adults With Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | a retrospective case-control study | |
| Region | Minnesota,USA | |
| Method | reviewed | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | direct current cardioversion (DCCV) | |
| Group | CHD group(Treatment) | control group(Control) |
| Number | 38 | 20 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.14 | 0.07 |
